Nephrology and Urology Devices Market is estimated to be US$ 8.98 billion by 2030 with a CAGR of 6.7% during the forecast period 2030

 

Nephrology And Urology Devices includes, stone basket, renal dilators, PCN catheters, urology guidewires, ureteral catheters and urinary sents. Main types of nephrology and urology devices are dialysis equipment, endoscopy devices, urinary stone treatment devices. Nephrology and Urology devices are used in treatment of chronic diseases like kidney stone, kidney diseases, urinary incontinence, urinary system. Dialyzer is the equipment used in dialysis. Hemodialysis, Continuous renal replacement therapy, Peritoneal dialysis are the different types of dialysis. Low-flux, High-flux and Protein leaking are the different types of dialyzer. Dialysis is used for filtration of blood. Rising prevalence of chronic diseases like kidney disease, urine disorder has favored the growth of the market. Rising awareness of newly advanced devices which are helpful in treatment has driven the major factor in nephrology and urology devices market growth. Growth in population has also increased the rise in market growth. Newly advancements in techniques like robotic systems has given rise in market growth. North America has become the dominating region due to high prevalence of chronic diseases. Global Nephrology and Urology Devices Market size accounted for US$ 4.9 billion in 2020 and is estimated to be US$ 8.98 billion by 2030 and is anticipated to register a CAGR of 6.7%.

The report “Global Nephrology and Urology Devices Market, By Type (Dialysis Equipment, Endoscopy Devices, Urinary Stone Treatment Devices, and Others), By Application (Diagnostic Laboratories, Hospitals, Clinics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

Key Highlights:

·         In 2017, Nanotechnology revolutionized the approach in medical diagnostics and applications in urology. The applications of nanotechnology in urology consists of robotic surgery, construction of artificial kidneys, biodegradable stents, therapy of genitourinary malignancies, overactive bladder and erectile dysfunction.

·         In 2015, Olympus company launched five new urology devices like, GLIDEWIRE Hydrophilic Coated Urologic Guidewire, ShockPulse – SE, UltraTrack Hybrid Guidewire, UroPass Access Sheath full portfolio and 200 Series Laser Fiber, which will provide enhanced patient satisfaction, increased quality of care, and decreased cost.

Analyst View:

Nephrology and Urology Devices innovation is growing around the world, owing to recent advancements. Rise in prevalence of chronic disease like heart disease, diabetes due to unhealthy lifestyle has led to increase in kidney diseases. Newly advanced technology in nephrology and urology devices has led to boosts the growth in market. Rise in chronic disease and newly advanced devices has given rise in use of nephrology and urology devices in clinics and hospitals. As a result, market competition is intensifying, and both big international corporations and start-ups are vying to establish position in the market.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2555

Key Market Insights from the report:

Global Nephrology and Urology Devices Market size accounted for US$ 4.9 billion in 2020 and is estimated to be US$ 8.98 billion by 2030 and is anticipated to register a CAGR of 6.7%.The Global Nephrology and Urology Devices Market is segmented based on Type, Application and Region.

·         Based on Type, Global Nephrology and Urology Devices Market is segmented into Dialysis Equipment, Endoscopy Devices, Urinary Stone Treatment Devices, and others.

·         Based on Application, Global Nephrology and Urology Devices Market is segmented into Diagnostic Laboratories, Hospitals, Clinics, and others.

·         By Region, the Global Nephrology and Urology Devices Market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Competitive Landscape & their strategies of Global Nephrology and Urology Devices Market:

The prominent players operating in the Global Nephrology and Urology Devices Market includes, J and M Urinary Catheters LLC., Olympus Corporation, Medtronic, ConvaTec Group PLC., Teleflex Incorporated, Boston Scientific Corporation, Baxter International Inc., NIPRO, Coloplast A/S, Richard Wolf GmbH, Stryker, Rocamed, Fresenius Medical Care AG & Co., Ambu A/S, Dornier Medtech, Ethicon Inc., Siemens Healthcare GmbH, and others.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Rare Disease Market is estimated to be US$ 547.5 billion by 2030 with a CAGR of 13.1% during the forecast period

Image
  Rare Disease Market  accounted for US$ 161.4 billion in 2020 and is estimated to be US$ 547.5 billion by 2030 and is anticipated to register a CAGR of 13.1%. Rare disease is any disease that affects a small percentage of the total population. In some parts of the world, an orphan disease is a rare disease whose rarity supports that there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions for creating and selling such treatments. Orphan drugs are ones in thousand so these drugs are created and sold boosting the market. The report "  Global Rare disease Market, By Drug Type (Biologics and Non-biologics),By Route of Administration (Oral and Injectable), By Phase (Preclinical, Phase1, Phase2, Phase3 and Phase4),  By Therapeutic Area (Infectious disease, Neurological, Alimentary/Metabolic, Cancer, Blood & Clotting and Others), By Patients (Neonat...
Read more

SCID Model Market is estimated to be US$ 61.95 million by 2030 with a CAGR of 4.6% during the forecast period

Image
  SCID Models Market   garnered a revenue of USD 43.50 Million in the year 2019 globally and has been foreseen to yield USD 61.95 Million by the year 2030 at a compound annual growth (CAGR) of 4.6% over the forecast period. Researchers are investigating the development of severe combined immunodeficient (SCID) pig models for translational cancer modelling. Several severe combined immunodeficient (SCID) pig models have been developed or genetically created in the previous decade. SCID pigs with NK cells but lacking in T and B cells, or defective in NK, T, and B cells for research investigations, have mutations in the ARTEMIS, IL2RG, or RAG1/2 genes, or combinations thereof. The report "Global SCID Model Market, By Model (Mouse, Pigs and Other), By Treatment (Stem Cell Therapy, Gene Therapy, and Enzyme Therapy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’ Key Highlights:...
Read more

Non-alcoholic Steatohepatitis Biomarkers Market accounted for US$ 556.6 billion in 2019 and is estimated to be US$ 8177.9 billion by 2029 and is anticipated to register a CAGR of 31.3%

Image
Non-alcoholic steatohepatitis   is a progressive phase of non-alcoholic fatty liver disease (NAFLD), which is caused due to the excess fat accumulation leading to inflammation and damage resulting to liver scarring. NASH biomarkers are used as diagnostic tools to measure the severity of non-alcoholic steatohepatitis and for the liver damage assessment. Emerging advancements in technology in biomarker identification for NASH is supporting in the NASH biomarker development. The report " Global  Non-alcoholic Steatohepatitis Biomarkers Market, By  Type (Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers, and Others), By End-user (Pharma & CRO Industry, Hospitals, Diagnostic Labs, and Academic Research Institutes),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In January 2019, LabCorp. a leading global...
Read more